Go Pro
→ Ready to give options a try? Your first trade (Ticker included) -INSIDE (From Base Camp Trading) (Ad)tc pixel Free CRIS Stock Alerts

Curis (CRIS) Financials

Curis logo
$1.70 0.00 (0.00%)
As of 12:10 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare
Annual Income Statements for Curis

Annual Income Statements for Curis

This table shows Curis' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -59 -60 -53 -33 -32 -30 -45 -57 -47 -43 -7.58
Consolidated Net Income / (Loss)		 -59 -60 -53 -33 -32 -30 -45 -57 -47 -43 -7.58
Net Income / (Loss) Continuing Operations		 -59 -60 -53 -33 -32 -30 -45 -57 -47 -43 -7.58
Total Pre-Tax Income 		-59 -60 -53 -33 -32 -30 -45 -57 -47 -43 -7.58
Total Operating Income		 -56 -58 -50 -29 -24 -25 -42 -53 -48 -45 -5.71
Total Gross Profit		 7.88 7.53 9.90 10 10 11 11 10 10 11 9.44
Total Revenue		 7.88 7.53 9.90 10 10 11 11 10 10 11 9.44
Operating Revenue		 7.88 7.53 9.90 10 10 11 11 10 10 11 9.44
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 64 66 60 40 34 36 53 63 58 55 15
Selling, General & Admin Expense		 13 16 14 15 12 12 17 20 19 17 14
Research & Development Expense		 51 50 45 24 22 23 35 43 39 39 28
Other Operating Expenses / (Income)		 0.41 0.40 0.50 0.56 0.50 0.53 0.53 0.26 0.21 0.10 0.05
Other Special Charges / (Income)		 - - - - - - - - - 0.00 -27
Total Other Income / (Expense), net		 -2.50 -2.37 -3.56 -3.24 -7.79 -5.01 -3.37 -3.65 0.92 1.15 -1.87
Interest Expense		 3.33 2.78 3.97 3.93 8.34 5.10 4.47 - - 0.62 2.19
Interest & Investment Income		 0.28 0.41 0.51 0.68 0.61 0.06 0.21 1.12 2.94 1.77 0.32
Basic Earnings per Share		 ($0.48) ($0.45) ($1.79) ($0.98) ($0.97) ($0.61) $0.50 ($12.14) ($8.96) ($6.88) ($0.58)
Weighted Average Basic Shares Outstanding		 123.37M 132.79M 29.83M 33.12M 33.18M 48.67M 91.57M 4.67M 5.29M 6.31M 13.16M
Diluted Earnings per Share		 ($0.48) ($0.45) ($1.79) ($0.98) ($0.97) ($0.61) $0.50 ($12.14) ($8.96) ($6.88) ($0.58)
Weighted Average Diluted Shares Outstanding		 123.37M 132.79M 29.83M 33.12M 33.18M 48.67M 91.57M 4.67M 5.29M 6.31M 13.16M
Weighted Average Basic & Diluted Shares Outstanding		 123.37M 132.79M 29.83M 33.12M 33.18M 48.67M 91.65M 96.62M 5.89M 8.49M 39.98M

Quarterly Income Statements for Curis

This table shows Curis' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -12 -12 -12 -12 -10 -9.62 -11 -8.59 -7.73 19 -24
Consolidated Net Income / (Loss)		 -12 -12 -12 -12 -10 -9.62 -11 -8.59 -7.73 19 -24
Net Income / (Loss) Continuing Operations		 -12 -12 -12 -12 -10 -9.62 -11 -8.59 -7.73 19 -24
Total Pre-Tax Income 		-12 -12 -12 -12 -10 -9.62 -11 -8.59 -7.73 19 -24
Total Operating Income		 -12 -12 -12 -13 -11 -8.99 -10 -8.25 -6.92 20 -12
Total Gross Profit		 2.83 2.72 2.09 2.55 2.93 3.35 2.38 2.75 3.18 1.14 0.00
Total Revenue		 2.83 2.70 2.09 2.55 2.93 3.35 2.38 2.75 3.18 1.14 0.00
Operating Revenue		 2.83 2.70 2.09 2.55 2.93 3.35 2.38 2.75 3.18 1.14 0.00
Total Cost of Revenue		 0.00 -0.02 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 15 15 15 15 13 12 13 11 10 -18 12
Selling, General & Admin Expense		 4.76 4.88 4.89 4.79 3.75 3.35 3.98 3.53 3.65 2.88 5.07
Research & Development Expense		 10 9.96 9.62 10 9.72 8.97 8.54 7.46 6.43 5.83 6.45
Other Operating Expenses / (Income)		 0.06 - 0.05 0.01 0.02 0.02 0.01 0.02 0.02 - 0.00
Total Other Income / (Expense), net		 0.19 0.42 0.59 0.71 0.48 -0.62 -0.46 -0.34 -0.81 -0.26 -13
Interest & Investment Income		 0.81 0.67 0.52 0.70 0.33 0.23 0.09 0.09 0.08 0.05 0.08
Other Income / (Expense), net		 - - 0.08 - 0.15 - 0.00 -0.43 - - -13
Basic Earnings per Share		 ($2.13) ($2.21) ($2.05) ($2.03) ($1.70) ($1.53) ($1.25) ($0.68) ($0.49) $1.84 ($1.25)
Weighted Average Basic Shares Outstanding		 5.72M 5.29M 5.78M 5.82M 5.94M 6.31M 8.49M 12.63M 15.68M 13.16M 19.36M
Diluted Earnings per Share		 ($2.13) ($2.21) ($2.05) ($2.03) ($1.70) ($1.53) ($1.25) ($0.68) ($0.49) $1.84 ($1.25)
Weighted Average Diluted Shares Outstanding		 5.72M 5.29M 5.78M 5.82M 5.94M 6.31M 8.49M 12.63M 15.68M 13.16M 19.36M
Weighted Average Basic & Diluted Shares Outstanding		 5.88M 5.89M 5.89M 5.98M 8.47M 8.49M 10.46M 12.50M 12.93M 39.98M 38.98M

Annual Cash Flow Statements for Curis

This table details how cash moves in and out of Curis' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 25 -7.05 12 -15 -7.39 114 -90 -20 6.93 -6.68 -15
Net Cash From Operating Activities		 -30 -36 -48 -30 -26 -26 -38 -54 -38 -40 -27
Net Cash From Continuing Operating Activities		 -30 -36 -48 -30 -26 -26 -38 -54 -38 -40 -27
Net Income / (Loss) Continuing Operations		 -59 -60 -53 -33 -32 -30 -45 -57 -47 -43 -7.58
Consolidated Net Income / (Loss)		 -59 -60 -53 -33 -32 -30 -45 -57 -47 -43 -7.58
Depreciation Expense		 0.16 0.20 0.20 0.18 0.13 0.14 0.16 0.23 0.26 0.20 0.17
Amortization Expense		 0.21 0.22 0.09 -0.11 -0.06 0.03 1.40 0.35 -1.06 -0.02 0.00
Non-Cash Adjustments To Reconcile Net Income		 28 22 5.36 3.95 6.42 2.94 3.52 8.57 7.00 7.36 -22
Changes in Operating Assets and Liabilities, net		 0.90 1.88 -0.72 -1.50 -0.56 1.05 2.74 -6.82 2.78 -3.72 1.75
Net Cash From Investing Activities		 -6.43 30 -3.63 21 -4.46 -49 -48 33 38 29 2.50
Net Cash From Continuing Investing Activities		 -6.43 30 -3.63 21 -4.46 -49 -48 33 38 29 2.50
Purchase of Investments		 -123 -58 -51 -27 -11 -53 -93 -62 -70 -18 0.00
Divestitures		 - - - - - - - - - 0.00 2.50
Sale and/or Maturity of Investments		 117 88 48 48 7.05 5.08 45 95 108 48 0.00
Net Cash From Financing Activities		 62 -1.37 64 -5.96 23 189 -4.17 0.87 7.58 3.44 9.77
Net Cash From Continuing Financing Activities		 62 -1.37 64 -5.96 23 189 -4.17 0.87 7.58 3.44 9.77
Issuance of Common Equity		 66 2.91 43 0.14 0.07 177 0.30 5.84 14 12 15
Other Financing Activities, net		 - - - 0.00 62 13 -4.47 -4.98 -6.54 -8.59 -5.59
Cash Interest Paid		 3.30 2.79 3.94 3.92 4.72 5.05 4.44 4.11 2.36 0.46 1.53

Quarterly Cash Flow Statements for Curis

This table details how cash moves in and out of Curis' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 4.56 2.21 3.28 -20 11 -0.86 0.29 -10 -1.09 -3.99 9.94
Net Cash From Operating Activities		 -8.18 -10 -13 -11 -5.94 -9.26 -7.25 -8.01 -5.57 -6.37 -9.00
Net Cash From Continuing Operating Activities		 -8.18 -10 -13 -11 -5.94 -9.26 -7.25 -8.01 -5.57 -6.37 -9.00
Net Income / (Loss) Continuing Operations		 -12 -12 -12 -12 -10 -9.62 -11 -8.59 -7.73 19 -24
Consolidated Net Income / (Loss)		 -12 -12 -12 -12 -10 -9.62 -11 -8.59 -7.73 19 -24
Depreciation Expense		 0.06 0.06 0.06 0.06 0.06 0.02 0.06 0.04 0.03 0.04 0.01
Non-Cash Adjustments To Reconcile Net Income		 1.84 1.89 1.84 2.03 0.61 2.88 1.16 1.45 1.29 -26 15
Changes in Operating Assets and Liabilities, net		 2.54 -0.41 -3.34 -0.89 3.48 -2.97 2.15 -0.91 0.84 -0.02 0.40
Net Cash From Investing Activities		 0.18 15 19 -7.36 18 -0.43 0.00 - - 2.50 0.00
Net Cash From Continuing Investing Activities		 0.18 15 19 -7.36 18 -0.43 0.00 - - 2.50 0.00
Net Cash From Financing Activities		 13 -2.12 -2.41 -1.46 -1.52 8.83 7.54 -2.14 4.48 -0.12 19
Net Cash From Continuing Financing Activities		 13 -2.12 -2.41 -1.46 -1.52 8.83 7.54 -2.14 4.48 -0.12 19
Issuance of Common Equity		 14 0.12 0.00 0.29 0.70 11 10 -0.58 6.05 -0.12 19
Other Financing Activities, net		 -1.26 -2.24 -2.41 -1.76 -2.22 -2.21 -2.46 -1.56 -1.57 - 0.00
Cash Interest Paid		 0.75 0.18 0.00 - - 0.46 0.45 0.35 0.73 0.00 0.00

Annual Balance Sheets for Curis

This table presents Curis' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 95 58 74 37 35 204 162 109 77 41 20
Total Current Assets		 86 48 64 28 25 173 122 92 61 26 6.92
Cash & Equivalents		 33 26 38 24 15 130 40 20 27 20 5.06
Prepaid Expenses		 1.20 1.26 0.99 0.83 1.06 1.22 3.27 3.52 1.78 3.04 1.85
Plant, Property, & Equipment, net		 0.28 0.41 0.37 0.27 0.15 0.66 0.51 0.69 0.43 0.23 0.06
Total Noncurrent Assets		 9.19 9.16 9.14 9.16 9.95 31 39 16 16 15 13
Goodwill		 8.98 9.00 8.98 9.00 8.98 8.98 8.98 8.98 8.98 8.98 8.98
Other Noncurrent Operating Assets		 0.05 0.00 0.00 0.16 0.97 7.40 6.48 7.06 6.96 5.67 4.01
Total Liabilities & Shareholders' Equity		 95 58 74 37 35 204 162 109 77 41 20
Total Liabilities		 30 28 50 42 69 74 72 62 58 47 15
Total Current Liabilities		 11 14 14 13 6.54 10 13 10 22 19 14
Accounts Payable		 4.22 5.88 5.42 2.91 4.47 4.17 6.42 3.19 3.17 3.02 5.61
Accrued Expenses		 1.93 2.73 2.79 3.46 1.91 3.63 6.34 5.68 9.04 7.11 7.27
Other Current Liabilities		 - - - - 0.17 1.73 0.68 1.14 1.31 1.34 1.19
Total Noncurrent Liabilities		 20 15 36 29 62 64 58 52 36 28 0.43
Other Noncurrent Operating Liabilities		 0.14 0.02 0.03 0.01 62 64 58 52 36 28 0.43
Total Equity & Noncontrolling Interests		 65 29 24 -4.50 -34 131 91 47 20 -6.00 5.46
Total Preferred & Common Equity		 65 29 24 -4.50 -34 131 91 47 20 -6.00 5.46
Preferred Stock		 - - - - - - - 0.00 0.00 0.00 0.00
Total Common Equity		 65 29 24 -4.50 -34 131 91 47 20 -6.00 5.46
Common Stock		 905 930 978 980 983 1,178 1,183 1,196 1,216 1,234 1,253
Retained Earnings		 -839 -899 -952 -985 -1,017 -1,047 -1,092 -1,149 -1,196 -1,240 -1,247

Quarterly Balance Sheets for Curis

This table presents Curis' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 90 62 50 42 39 29 28 30
Total Current Assets		 73 46 35 27 25 14 14 17
Cash & Equivalents		 24 30 10.00 21 20 10 9.05 15
Prepaid Expenses		 2.08 3.19 3.62 3.11 2.21 1.53 1.61 1.61
Plant, Property, & Equipment, net		 0.50 0.37 0.31 0.25 0.17 0.13 0.10 0.05
Total Noncurrent Assets		 16 16 16 15 14 15 14 13
Goodwill		 8.98 8.98 8.98 8.98 8.98 8.98 8.98 8.98
Other Noncurrent Operating Assets		 7.07 6.61 6.60 6.31 5.36 5.70 4.65 4.04
Total Liabilities & Shareholders' Equity		 90 62 50 42 39 29 28 30
Total Liabilities		 60 53 51 51 46 43 42 17
Total Current Liabilities		 14 11 19 22 20 19 20 15
Accounts Payable		 5.22 3.63 2.45 3.82 5.10 4.10 4.45 6.74
Accrued Expenses		 7.23 6.33 6.74 8.14 6.48 6.66 7.29 7.00
Other Current Liabilities		 1.26 1.35 10 10 1.30 1.27 1.23 1.23
Total Noncurrent Liabilities		 47 41 32 29 26 24 22 2.01
Other Noncurrent Operating Liabilities		 47 41 32 29 26 24 22 2.01
Total Equity & Noncontrolling Interests		 30 9.46 -0.69 -8.74 -6.61 -14 -15 13
Total Preferred & Common Equity		 30 9.46 -0.69 -8.74 -6.61 -14 -15 13
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 30 9.46 -0.69 -8.74 -6.61 -14 -15 13
Common Stock		 1,214 1,217 1,219 1,221 1,244 1,245 1,252 1,284
Retained Earnings		 -1,185 -1,208 -1,220 -1,230 -1,250 -1,259 -1,267 -1,272

Annual Metrics And Ratios for Curis

This table displays calculated financial ratios and metrics derived from Curis' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 128,394,655.00 140,549,019.00 163,983,755.00 33,113,146.00 33,202,871.00 58,817,444.00 91,609,165.00 96,398,360.00 5,883,063.00 8,466,957.00 12,928,853.00
DEI Adjusted Shares Outstanding		 1,283,947.00 1,405,490.00 1,639,838.00 1,655,657.00 1,660,144.00 2,940,872.00 4,580,458.00 4,819,918.00 5,883,063.00 8,466,957.00 12,928,853.00
DEI Earnings Per Adjusted Shares Outstanding		 -45.94 -42.98 -32.51 -19.68 -19.36 -10.17 -9.92 -11.76 -8.06 -5.12 -0.59
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -19.96% -4.46% 31.50% 5.35% -4.07% 8.31% -1.72% -4.57% -1.37% 8.83% -13.43%
EBITDA Growth		 -277.21% -3.70% 13.97% 40.96% 16.82% -1.45% -60.39% -44.41% 10.58% 13.29% 87.50%
EBIT Growth		 -269.32% -3.77% 14.09% 41.17% 16.77% -1.89% -65.52% -40.35% 12.87% 11.54% 87.17%
NOPAT Growth		 -256.08% -2.76% 14.26% 41.05% 16.97% -2.23% -68.95% -26.04% 8.84% 7.84% 87.17%
Net Income Growth		 -214.92% -2.42% 11.74% 38.90% 1.33% 6.95% -51.92% -24.73% 16.34% 8.49% 82.53%
EPS Growth		 -118.18% 6.25% 11.74% 45.25% 1.02% 37.11% 181.97% -24.73% 26.19% 23.21% 91.57%
Operating Cash Flow Growth		 -77.79% -19.81% -35.03% 37.82% 12.84% 1.78% -46.16% -44.44% 29.27% -2.94% 31.25%
Free Cash Flow Firm Growth		 -225.13% -0.81% 8.54% 37.71% 300.37% -145.62% -59.05% -46.83% 5.17% 8.59% 44.16%
Invested Capital Growth		 -14.18% -28.83% 14.58% 30.47% -910.67% 5.08% 5.19% 20.49% 27.93% 34.52% 102.17%
Revenue Q/Q Growth		 1.37% 3.73% 10.00% -4.64% 5.62% 0.00% 0.00% -2.38% -1.87% 6.33% -18.94%
EBITDA Q/Q Growth		 -16.65% 4.25% 6.47% 5.79% -8.95% -14,978.92% -3,518.03% -5.65% -7.89% 7.51% 83.57%
EBIT Q/Q Growth		 -16.42% 4.10% 6.80% 6.32% -10.12% 0.00% 0.00% -4.38% -8.63% 6.71% 83.36%
NOPAT Q/Q Growth		 -17.56% 4.10% 6.81% 6.32% -9.86% 0.00% 0.00% 4.24% -4.27% 6.71% 83.36%
Net Income Q/Q Growth		 -15.18% 3.40% 5.84% 6.02% -9.05% 0.00% 0.00% 3.89% -0.81% 4.60% 79.26%
EPS Q/Q Growth		 -20.00% 4.26% 5.84% 6.67% -8.99% 0.00% 0.00% 3.89% -9.00% 10.18% 75.11%
Operating Cash Flow Q/Q Growth		 -26.01% 3.96% 3.75% 7.86% -2.58% -0.45% -6.98% -8.15% 5.14% 2.29% 9.60%
Free Cash Flow Firm Q/Q Growth		 -12.98% 2.34% 1.56% 11.30% -2.87% -325.45% -1,178.26% -10.42% -22.64% 4.31% 37.98%
Invested Capital Q/Q Growth		 -19.84% -14.40% 31.14% -2.97% -0.79% -4.86% -4.74% 9.02% 27.62% 37.68% 102.39%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -705.34% -765.56% -500.84% -280.67% -243.35% -227.96% -372.01% -562.95% -510.38% -406.63% -58.71%
Operating Margin		 -716.95% -771.08% -502.73% -281.29% -243.46% -229.79% -395.01% -521.75% -482.21% -408.34% -60.50%
EBIT Margin		 -709.99% -771.09% -503.78% -281.29% -244.04% -229.59% -386.66% -568.70% -502.35% -408.34% -60.50%
Profit (Net Income) Margin		 -748.68% -802.59% -538.66% -312.38% -321.28% -276.03% -426.67% -557.69% -473.04% -397.77% -80.29%
Tax Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 105.45% 104.09% 106.92% 111.05% 131.65% 120.23% 110.35% 98.06% 94.17% 97.41% 132.71%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -576.83% -749.79% -720.49% -345.12% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 -528.57% -702.08% -635.68% -28.15% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 451.73% 620.95% 520.27% 10.97% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -125.10% -128.84% -200.22% -334.15% 167.37% -61.82% -41.05% -82.58% -143.19% -634.71% 2,829.10%
Cash Return on Invested Capital (CROIC)		 -561.57% -716.11% -734.08% -371.56% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -5,695.54%
Operating Return on Assets (OROA)		 -70.99% -76.01% -75.81% -52.77% -67.38% -20.78% -22.46% -42.63% -54.10% -75.15% -18.66%
Return on Assets (ROA)		 -74.86% -79.12% -81.06% -58.61% -88.70% -24.98% -24.78% -41.80% -50.95% -73.20% -24.77%
Return on Common Equity (ROCE)		 -125.10% -128.84% -200.22% -334.15% 167.37% -61.82% -41.05% -82.58% -143.19% -634.71% 2,829.10%
Return on Equity Simple (ROE_SIMPLE)		 -91.43% -206.42% -222.22% 724.53% 94.78% -22.89% -50.09% -121.74% -241.04% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -40 -41 -35 -21 -17 -17 -29 -37 -34 -31 -4.00
NOPAT Margin		 -501.86% -539.75% -351.91% -196.90% -170.42% -160.85% -276.51% -365.22% -337.55% -285.84% -42.35%
Net Nonoperating Expense Percent (NNEP)		 -48.26% -47.71% -84.81% -316.98% -318.93% -12.28% -9.92% -17.35% -20.35% -40.52% -40.94%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -120.08% -2,001.25% -73.22%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 163.82% 207.09% 142.11% 141.78% 115.50% 111.96% 162.43% 193.35% 186.04% 153.92% 148.75%
R&D to Revenue		 647.97% 658.68% 455.61% 234.11% 222.93% 212.90% 327.58% 425.87% 394.05% 353.52% 299.21%
Operating Expenses to Revenue		 816.95% 871.08% 602.73% 381.29% 343.46% 329.79% 495.01% 621.75% 582.21% 508.34% 160.50%
Earnings before Interest and Taxes (EBIT)		 -56 -58 -50 -29 -24 -25 -41 -58 -50 -45 -5.71
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -56 -58 -50 -29 -24 -25 -40 -57 -51 -44 -5.54
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.79 14.79 4.78 0.00 0.00 3.69 4.81 1.14 3.81 0.00 2.34
Price to Tangible Book Value (P/TBV)		 6.73 21.36 7.65 0.00 0.00 3.96 5.34 1.41 7.02 0.00 0.00
Price to Revenue (P/Rev)		 47.43 57.51 11.60 2.19 5.64 44.46 40.95 5.22 7.48 2.38 1.35
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 49.83 90.57 18.59 5.06 0.00 0.00 0.00 0.00 0.00 0.00 19.20
Enterprise Value to Revenue (EV/Rev)		 40.04 54.22 9.69 3.27 3.57 27.62 27.82 0.00 2.71 1.23 0.82
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.81 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.37 0.68 1.73 -7.89 0.00 0.00 0.00 0.00 0.43 -1.26 0.00
Long-Term Debt to Equity		 0.30 0.51 1.49 -6.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.85 -0.88 -0.82 -0.39 0.25 -2.10 -1.46 -1.64 -2.02 -4.41 32.65
Leverage Ratio		 1.67 1.63 2.47 5.70 -1.89 2.47 1.66 1.98 2.81 8.67 -114.24
Compound Leverage Factor		 1.76 1.70 2.64 6.33 -2.48 2.98 1.83 1.94 2.65 8.45 -151.61
Debt to Total Capital		 27.25% 40.43% 63.40% 114.51% 0.00% 0.42% 0.00% 0.00% 30.18% 484.98% 0.00%
Short-Term Debt to Total Capital		 5.20% 10.05% 8.98% 22.22% 0.00% 0.42% 0.00% 0.00% 30.18% 484.98% 0.00%
Long-Term Debt to Total Capital		 22.06% 30.37% 54.42% 92.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 72.75% 59.57% 36.60% -14.51% 100.00% 99.58% 100.00% 100.00% 69.82% -384.98% 100.00%
Debt to EBITDA		 -0.43 -0.34 -0.84 -1.21 0.00 -0.02 0.00 0.00 -0.17 -0.17 0.00
Net Debt to EBITDA		 1.05 0.43 0.38 -0.38 0.00 7.39 0.00 0.00 0.94 0.28 0.00
Long-Term Debt to EBITDA		 -0.35 -0.26 -0.72 -0.98 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.61 -0.49 -1.19 -1.73 0.00 -0.03 0.00 0.00 -0.25 -0.24 0.00
Net Debt to NOPAT		 1.47 0.61 0.54 -0.55 0.00 10.47 0.00 0.00 1.41 0.40 0.00
Long-Term Debt to NOPAT		 -0.49 -0.37 -1.02 -1.39 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -5.92 -15.14 -17.96 -38.41 -41.44 -2.64 -5.73 -15.02 -22.31 -44.82 -87.84
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 7.95 3.56 4.56 2.11 3.82 17.14 9.11 9.20 2.77 1.39 0.49
Quick Ratio		 7.84 3.47 4.49 2.05 3.64 17.02 8.86 8.85 2.69 1.23 0.36
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -38 -39 -35 -22 44 -20 -32 -47 -45 -41 -23
Operating Cash Flow to CapEx		 -124,545.83% -10,884.80% -25,720.74% -35,370.59% -63,914.63% -3,801.92% 0.00% -13,061.78% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -11.58 -13.97 -8.95 -5.63 5.31 -3.97 -7.19 0.00 0.00 -66.50 -10.45
Operating Cash Flow to Interest Expense		 -8.99 -12.90 -12.19 -7.66 -3.14 -5.05 -8.41 0.00 0.00 -64.33 -12.45
Operating Cash Flow Less CapEx to Interest Expense		 -9.00 -13.01 -12.24 -7.68 -3.15 -5.18 -8.41 0.00 0.00 -64.33 -12.45
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.10 0.10 0.15 0.19 0.28 0.09 0.06 0.08 0.11 0.18 0.31
Accounts Receivable Turnover		 3.87 3.30 3.58 3.51 3.28 3.45 3.40 3.28 3.47 3.55 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 22.98 21.79 25.41 32.95 47.52 26.52 18.23 17.02 17.85 32.81 64.46
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 94.22 110.68 102.00 103.90 111.43 105.90 107.40 111.33 105.04 102.78 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 94.22 110.68 102.00 103.90 111.43 105.90 107.40 111.33 105.04 102.78 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 6.33 4.51 5.16 6.74 -55 -52 -49 -39 -28 -18 0.40
Invested Capital Turnover		 1.15 1.39 2.05 1.75 -0.42 -0.20 -0.21 -0.23 -0.30 -0.47 -1.05
Increase / (Decrease) in Invested Capital		 -1.05 -1.83 0.66 1.57 -61 2.78 2.69 10 11 9.72 19
Enterprise Value (EV)		 315 408 96 34 36 299 296 -33 27 13 7.70
Market Capitalization		 374 433 115 23 56 482 436 53 75 26 13
Book Value per Share		 $0.50 $0.21 $0.15 ($0.14) ($1.02) $2.22 $0.99 $0.48 $3.72 ($0.71) $0.42
Tangible Book Value per Share		 $0.43 $0.14 $0.09 ($0.41) ($1.29) $2.07 $0.89 $0.39 $2.02 ($1.77) ($0.27)
Total Capital		 89 49 66 31 -34 131 91 47 28 1.56 5.46
Total Debt		 24 20 42 35 0.00 0.56 0.00 0.00 8.50 7.56 0.00
Total Long-Term Debt		 20 15 36 29 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -58 -25 -19 11 -21 -183 -140 -86 -48 -12 -5.06
Capital Expenditures (CapEx)		 0.02 0.33 0.19 0.09 0.04 0.68 0.00 0.42 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -2.84 -4.89 -4.15 -2.68 -2.23 -5.26 -6.95 -3.52 -8.94 -5.08 -12
Debt-free Net Working Capital (DFNWC)		 79 40 56 22 18 163 109 82 47 15 -7.16
Net Working Capital (NWC)		 75 35 50 15 18 163 109 82 39 7.36 -7.16
Net Nonoperating Expense (NNE)		 19 20 18 12 15 12 16 20 14 12 3.58
Net Nonoperating Obligations (NNO)		 -58 -25 -19 11 -21 -183 -140 -86 -48 -12 -5.06
Total Depreciation and Amortization (D&A)		 0.37 0.42 0.29 0.07 0.07 0.18 1.56 0.58 -0.80 0.19 0.17
Debt-free, Cash-free Net Working Capital to Revenue		 -36.06% -64.99% -41.97% -25.65% -22.33% -48.58% -65.24% -34.61% -89.22% -46.60% -129.43%
Debt-free Net Working Capital to Revenue		 1,007.24% 526.01% 566.56% 207.09% 184.55% 1,506.51% 1,022.98% 807.97% 472.82% 136.73% -75.83%
Net Working Capital to Revenue		 948.76% 460.40% 507.09% 141.07% 184.55% 1,501.37% 1,022.98% 807.97% 387.98% 67.46% -75.83%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($48.00) ($45.00) ($36.00) ($19.60) ($19.40) ($12.20) ($10.00) $12.20 ($8.96) ($6.88) ($0.58)
Adjusted Weighted Average Basic Shares Outstanding		 1.29M 1.42M 1.66M 1.66M 1.83M 4.58M 4.58M 4.67M 5.29M 6.31M 13.16M
Adjusted Diluted Earnings per Share		 ($48.00) ($45.00) ($36.00) ($19.60) ($19.40) ($12.20) ($10.00) $12.20 ($8.96) ($6.88) ($0.58)
Adjusted Weighted Average Diluted Shares Outstanding		 1.29M 1.42M 1.66M 1.66M 1.83M 4.58M 4.58M 4.67M 5.29M 6.31M 13.16M
Adjusted Basic & Diluted Earnings per Share		 ($48.00) ($45.00) ($36.00) ($19.60) ($19.40) ($12.20) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 1.23M 1.33M 1.49M 1.66M 1.66M 2.43M 4.58M 4.83M 5.89M 8.49M 39.98M
Normalized Net Operating Profit after Tax (NOPAT)		 -40 -41 -35 -21 -17 -17 -29 -37 -34 -31 -23
Normalized NOPAT Margin		 -501.86% -539.75% -351.91% -196.90% -170.42% -160.85% -276.51% -365.22% -337.55% -285.84% -243.90%
Pre Tax Income Margin		 -748.68% -802.59% -538.66% -312.38% -321.28% -276.03% -426.67% -557.69% -473.04% -397.77% -80.29%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -16.82 -20.90 -12.57 -7.47 -2.93 -4.88 -9.21 0.00 0.00 -72.43 -2.61
NOPAT to Interest Expense		 -11.89 -14.63 -8.78 -5.23 -2.04 -3.42 -6.58 0.00 0.00 -50.70 -1.83
EBIT Less CapEx to Interest Expense		 -16.83 -21.02 -12.62 -7.49 -2.93 -5.02 -9.21 0.00 0.00 -72.43 -2.61
NOPAT Less CapEx to Interest Expense		 -11.90 -14.75 -8.83 -5.25 -2.05 -3.55 -6.58 0.00 0.00 -50.70 -1.83
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -6.01% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Curis

This table displays calculated financial ratios and metrics derived from Curis' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 117,704,554.00 5,883,063.00 5,883,063.00 5,894,085.00 5,978,945.00 8,466,957.00 8,487,818.00 10,462,250.00 12,498,853.00 12,928,853.00 39,978,693.00
DEI Adjusted Shares Outstanding		 5,885,228.00 5,883,063.00 5,883,063.00 5,894,085.00 5,978,945.00 8,466,957.00 8,487,818.00 10,462,250.00 12,498,853.00 12,928,853.00 39,978,693.00
DEI Earnings Per Adjusted Shares Outstanding		 -2.07 -1.99 -2.02 -2.00 -1.69 -1.14 -1.25 -0.82 -0.62 1.50 -0.61
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.28% -6.62% -9.19% 15.89% 3.46% 24.07% 14.09% 7.97% 8.36% -65.98% -100.00%
EBITDA Growth		 5.52% -16.51% -5.18% -3.62% 18.80% 29.63% 17.52% 33.43% 33.41% 329.88% -140.32%
EBIT Growth		 9.25% -19.36% -7.20% -3.08% 15.77% 26.27% 18.03% 30.59% 33.53% 318.13% -139.01%
NOPAT Growth		 1.89% -19.36% -7.24% -3.08% 14.56% 26.27% 18.54% 34.06% 34.48% 411.62% -13.41%
Net Income Growth		 8.37% -3.38% -2.74% 1.32% 17.15% 17.88% 10.61% 27.20% 23.41% 301.25% -127.95%
EPS Growth		 24.74% 9.05% 14.23% 17.81% 20.19% 30.77% 39.02% 66.50% 71.18% 220.26% 0.00%
Operating Cash Flow Growth		 37.65% 16.97% -8.47% -41.52% 27.44% 9.09% 45.19% 28.07% 6.18% 31.20% -24.12%
Free Cash Flow Firm Growth		 0.80% -12.93% 28.38% -3.53% -31.67% 17.65% -48.05% -6.43% -5.56% 104.86% -35.87%
Invested Capital Growth		 9.40% 27.93% 11.12% 22.03% 23.95% 34.52% 37.12% 42.28% 43.25% 102.17% 88.33%
Revenue Q/Q Growth		 28.95% -4.84% -22.63% 22.05% 15.12% 14.12% -28.85% 15.50% 15.53% -64.17% -100.00%
EBITDA Q/Q Growth		 -1.72% 4.68% -0.77% -6.05% 20.29% 17.39% -18.11% 14.41% 20.26% 385.19% -223.47%
EBIT Q/Q Growth		 -1.89% 1.37% -1.57% -0.98% 16.74% 13.66% -12.93% 14.49% 20.28% 383.35% -223.74%
NOPAT Q/Q Growth		 -1.89% 1.37% -2.21% -0.34% 15.55% 14.89% -12.93% 18.77% 16.08% 504.78% -141.10%
Net Income Q/Q Growth		 -1.84% 3.85% -1.40% 0.61% 14.50% 4.70% -10.38% 19.06% 10.05% 350.43% -225.02%
EPS Q/Q Growth		 13.77% -3.76% 7.24% 0.98% 16.26% 10.00% 18.30% 45.60% 27.94% 475.51% -167.93%
Operating Cash Flow Q/Q Growth		 -3.98% -24.51% -29.90% 15.85% 46.69% -56.00% 21.68% -10.44% 30.47% -14.40% -41.28%
Free Cash Flow Firm Q/Q Growth		 22.54% -53.22% 35.02% -34.24% 1.49% 4.18% -16.83% 3.50% 2.29% 104.41% -3,363.71%
Invested Capital Q/Q Growth		 -4.41% 27.62% -11.00% 7.05% -1.84% 37.68% -6.59% 14.67% -0.12% 102.39% -672.07%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.89% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 0.00%
EBITDA Margin		 -449.95% -450.67% -586.91% -509.98% -353.12% -255.61% -424.29% -314.41% -217.00% 1,727.15% 0.00%
Operating Margin		 -436.57% -452.49% -597.75% -491.44% -360.53% -268.88% -426.76% -300.15% -218.01% 1,723.99% 0.00%
EBIT Margin		 -436.57% -452.49% -594.01% -491.44% -355.41% -268.88% -426.76% -315.93% -218.01% 1,723.99% 0.00%
Profit (Net Income) Margin		 -429.97% -434.42% -569.32% -463.59% -344.32% -287.53% -446.05% -312.59% -243.36% 1,700.88% 0.00%
Tax Burden Percent		 100.00% 99.42% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Interest Burden Percent		 98.49% 96.57% 95.84% 94.33% 96.88% 106.94% 104.52% 98.94% 111.63% 98.66% 99.68%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -110.22% -143.19% -207.29% -372.68% -436.16% -634.71% -2,951.24% 530.23% 312.10% 2,829.10% -693.93%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -5,695.54% 0.00%
Operating Return on Assets (OROA)		 -41.90% -48.73% -74.45% -74.13% -55.06% -49.48% -94.34% -90.48% -72.45% 531.74% 0.00%
Return on Assets (ROA)		 -41.27% -46.79% -71.36% -69.93% -53.34% -52.91% -98.60% -89.52% -80.87% 524.62% 0.00%
Return on Common Equity (ROCE)		 -110.22% -143.19% -207.29% -372.68% -436.16% -634.71% -2,951.24% 530.23% 312.10% 2,829.10% -693.93%
Return on Equity Simple (ROE_SIMPLE)		 -158.93% 0.00% -504.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -8.66 -8.54 -8.73 -8.76 -7.40 -6.30 -7.11 -5.78 -4.85 20 -8.06
NOPAT Margin		 -305.60% -316.74% -418.42% -344.01% -252.37% -188.22% -298.74% -210.10% -152.61% 1,723.99% 0.00%
Net Nonoperating Expense Percent (NNEP)		 -4.21% -4.75% -5.60% -6.63% -6.03% -11.02% -13.04% -18.09% -25.11% -3.01% -115.05%
Return On Investment Capital (ROIC_SIMPLE)		 - -30.31% -92.25% 1,262.02% 84.68% -404.10% -1,133.96% 87.08% 62.62% 359.19% -63.46%
Cost of Revenue to Revenue		 0.00% -0.89% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 168.06% 180.90% 234.47% 188.22% 128.05% 100.27% 167.40% 128.26% 115.02% 253.34% 0.00%
R&D to Revenue		 366.40% 369.58% 461.03% 402.75% 331.73% 268.10% 358.78% 271.30% 202.52% 511.86% 0.00%
Operating Expenses to Revenue		 536.57% 553.38% 697.75% 591.44% 460.53% 368.88% 526.76% 400.15% 318.01% -1,623.99% 0.00%
Earnings before Interest and Taxes (EBIT)		 -12 -12 -12 -13 -10 -8.99 -10 -8.69 -6.92 20 -24
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -13 -12 -12 -13 -10 -8.55 -10 -8.64 -6.89 20 -24
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.31 3.81 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.34 1.72
Price to Tangible Book Value (P/TBV)		 1.88 7.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.87
Price to Revenue (P/Rev)		 3.80 7.48 0.00 4.00 3.14 2.38 1.59 2.13 1.78 1.35 3.10
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.20 0.00
Enterprise Value to Revenue (EV/Rev)		 0.00 2.71 0.00 1.21 1.11 1.23 0.43 1.88 1.60 0.82 0.97
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.43 0.00 0.00 0.00 -1.26 -1.09 -0.53 -0.47 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.96 -2.02 -2.44 -3.60 -4.28 -4.41 -18.83 2.12 0.98 32.65 -4.60
Leverage Ratio		 2.49 2.81 3.40 5.28 6.35 8.67 35.50 -5.43 -2.99 -114.24 11.31
Compound Leverage Factor		 2.46 2.71 3.26 4.98 6.15 9.27 37.10 -5.37 -3.34 -112.71 11.28
Debt to Total Capital		 0.00% 30.18% 0.00% 0.00% 0.00% 484.98% 1,153.75% -110.85% -89.81% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 30.18% 0.00% 0.00% 0.00% 484.98% 1,153.75% -110.85% -89.81% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 69.82% 100.00% 100.00% 100.00% -384.98% -1,053.75% 210.85% 189.81% 100.00% 100.00%
Debt to EBITDA		 0.00 -0.17 0.00 0.00 0.00 -0.17 -0.17 -0.20 -0.21 0.00 0.00
Net Debt to EBITDA		 0.00 0.94 0.00 0.00 0.00 0.28 0.31 0.07 0.06 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 -0.25 0.00 0.00 0.00 -0.24 -0.24 -0.28 -0.29 0.00 0.00
Net Debt to NOPAT		 0.00 1.41 0.00 0.00 0.00 0.40 0.44 0.10 0.09 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 -17.59 -20.68 0.00 -33.66 -40.60 -41.97 -44.71 -60.75 -64.53 -83.65 -61.59
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 5.36 2.77 4.08 1.78 1.22 1.39 1.23 0.74 0.70 0.49 1.11
Quick Ratio		 5.20 2.69 3.79 1.60 1.08 1.23 1.12 0.67 0.62 0.36 1.00
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -13 -19 -13 -17 -17 -16 -19 -18 -18 0.78 -25
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense		 -20.51 0.00 0.00 0.00 0.00 0.00 -33.90 0.00 -19.94 0.00 0.00
Operating Cash Flow to Interest Expense		 -13.22 0.00 0.00 0.00 0.00 0.00 -13.14 0.00 -6.29 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 -13.22 0.00 0.00 0.00 0.00 0.00 -13.14 0.00 -6.29 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.10 0.11 0.13 0.15 0.15 0.18 0.22 0.29 0.33 0.31 0.20
Accounts Receivable Turnover		 3.56 3.47 4.39 4.12 3.52 3.55 5.01 4.31 3.75 0.00 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 16.00 17.85 19.72 23.39 27.62 32.81 41.34 52.08 67.73 64.46 62.50
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 102.45 105.04 83.10 88.58 103.64 102.78 72.81 84.78 97.45 0.00 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 83,470.94 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 -83,368.48 105.04 83.10 88.58 103.64 102.78 72.81 84.78 97.45 0.00 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -39 -28 -31 -29 -30 -18 -20 -17 -17 0.40 -2.29
Invested Capital Turnover		 -0.25 -0.30 -0.30 -0.31 -0.30 -0.47 -0.44 -0.50 -0.50 -1.05 -0.64
Increase / (Decrease) in Invested Capital		 4.04 11 3.91 8.21 9.32 9.72 12 12 13 19 17
Enterprise Value (EV)		 -30 27 0.00 12 11 13 4.78 21 19 7.70 6.88
Market Capitalization		 39 75 0.00 41 32 26 18 24 21 13 22
Book Value per Share		 $0.25 $3.72 $1.64 ($0.12) ($1.46) ($0.71) ($0.78) ($1.34) ($1.18) $0.42 $0.32
Tangible Book Value per Share		 $0.18 $2.02 $0.08 ($1.64) ($2.96) ($1.77) ($1.84) ($2.20) ($1.89) ($0.27) $0.09
Total Capital		 30 28 9.46 -0.69 -8.74 1.56 0.63 -6.63 -7.74 5.46 13
Total Debt		 0.00 8.50 0.00 0.00 0.00 7.56 7.23 7.35 6.95 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -68 -48 -41 -28 -21 -12 -13 -2.79 -2.10 -5.06 -15
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -8.78 -8.94 -5.96 -13 -16 -5.08 -8.35 -7.74 -8.11 -12 -13
Debt-free Net Working Capital (DFNWC)		 60 47 35 15 4.90 15 12 2.40 0.95 -7.16 1.64
Net Working Capital (NWC)		 60 39 35 15 4.90 7.36 4.69 -4.95 -6.01 -7.16 1.64
Net Nonoperating Expense (NNE)		 3.52 3.17 3.15 3.04 2.70 3.32 3.51 2.82 2.88 0.26 16
Net Nonoperating Obligations (NNO)		 -68 -48 -41 -28 -21 -12 -13 -2.79 -2.10 -5.06 -15
Total Depreciation and Amortization (D&A)		 -0.38 0.05 0.15 -0.47 0.07 0.44 0.06 0.04 0.03 0.04 0.01
Debt-free, Cash-free Net Working Capital to Revenue		 -85.96% -89.22% -60.71% -129.93% -155.48% -46.60% -74.58% -67.85% -69.57% -129.43% -189.21%
Debt-free Net Working Capital to Revenue		 584.67% 472.82% 354.29% 149.18% 47.79% 136.73% 106.48% 21.04% 8.12% -75.83% 23.18%
Net Working Capital to Revenue		 584.67% 387.98% 354.29% 149.18% 47.79% 67.46% 41.90% -43.43% -51.55% -75.83% 23.18%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($2.13) ($2.21) ($2.05) ($2.03) ($1.70) ($1.53) ($1.25) ($0.68) ($0.49) $1.84 ($1.25)
Adjusted Weighted Average Basic Shares Outstanding		 5.72M 5.29M 5.78M 5.82M 5.94M 6.31M 8.49M 12.63M 15.68M 13.16M 19.36M
Adjusted Diluted Earnings per Share		 ($2.13) ($2.21) ($2.05) ($2.03) ($1.70) ($1.53) ($1.25) ($0.68) ($0.49) $1.84 ($1.25)
Adjusted Weighted Average Diluted Shares Outstanding		 5.72M 5.29M 5.78M 5.82M 5.94M 6.31M 8.49M 12.63M 15.68M 13.16M 19.36M
Adjusted Basic & Diluted Earnings per Share		 $0.00 ($2.21) $0.00 $0.00 $0.00 ($1.53) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 5.88M 5.89M 5.89M 5.98M 8.47M 8.49M 10.46M 12.50M 12.93M 39.98M 38.98M
Normalized Net Operating Profit after Tax (NOPAT)		 -8.66 -8.54 -8.73 -8.76 -7.40 -6.30 -7.11 -5.78 -4.85 14 -8.06
Normalized NOPAT Margin		 -305.60% -316.74% -418.42% -344.01% -252.37% -188.22% -298.74% -210.10% -152.61% 1,206.79% 0.00%
Pre Tax Income Margin		 -429.97% -436.94% -569.32% -463.59% -344.32% -287.53% -446.05% -312.59% -243.36% 1,700.88% 0.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -19.98 0.00 0.00 0.00 0.00 0.00 -18.40 0.00 -7.82 0.00 0.00
NOPAT to Interest Expense		 -13.99 0.00 0.00 0.00 0.00 0.00 -12.88 0.00 -5.48 0.00 0.00
EBIT Less CapEx to Interest Expense		 -19.98 0.00 0.00 0.00 0.00 0.00 -18.40 0.00 -7.82 0.00 0.00
NOPAT Less CapEx to Interest Expense		 -13.99 0.00 0.00 0.00 0.00 0.00 -12.88 0.00 -5.48 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Curis’ financial statements show a biotechnology company that remains dependent on external financing while operating revenue has weakened. Revenue declined from $3.3 million in the fourth quarter of 2024 to $1.1 million in the fourth quarter of 2025, before falling to zero in the first quarter of 2026. The company reported a $24.2 million net loss in Q1 2026, compared with a $19.4 million profit in Q4 2025. The latest loss was driven in part by $12.8 million of net other expense.

Cash generation remains a major concern. Curis used $9.0 million in operating cash during Q1 2026, following operating cash outflows of $6.4 million in Q4 2025, $5.6 million in Q3 2025 and $8.0 million in Q2 2025. The company ended Q1 2026 with $15.0 million in cash, but increased cash by $9.9 million during the quarter primarily through a $18.9 million common-stock issuance.

  • Curis’ balance sheet improved from Q3 2025 to Q1 2026: total liabilities declined from $42.3 million to $17.0 million, while shareholders’ equity turned positive at $12.7 million from negative equity of $14.7 million.
  • Cash increased from $9.1 million at the end of Q3 2025 to $15.0 million at the end of Q1 2026, helped by $18.9 million of equity financing in the latest quarter.
  • Selling, general and administrative expense decreased to $5.1 million in Q1 2026 from $5.8 million in Q4 2025 and $8.5 million in Q1 2025, indicating some reduction in administrative spending compared with earlier periods.
  • The company continues to allocate substantial resources to research and development, with Q1 2026 R&D expense of $6.4 million. This spending could support future clinical or licensing opportunities if Curis’ programs produce favorable results.
  • Curis reported zero revenue in Q1 2026, so current results provide little evidence of an established commercial revenue base. Earlier quarterly revenue ranged from $2.1 million to $3.3 million during 2024 and early 2025.
  • Q4 2025’s $19.4 million profit was a sharp departure from the company’s recurring losses and appears inconsistent with the underlying operating trend. Investors should not assume that quarter’s earnings level is sustainable.
  • Operating losses have persisted across most reported quarters. Q1 2026 operating loss was $11.5 million, compared with operating losses of $18.5 million in Q4 2025, $6.9 million in Q3 2025 and $8.3 million in Q2 2025.
  • Operating cash flow has been negative in every supplied quarter from Q3 2023 through Q1 2026. The $9.0 million Q1 2026 burn rate would consume a substantial portion of the company’s $15.0 million cash balance without additional financing or a meaningful change in spending.
  • The latest increase in cash depended on equity financing rather than operations. Weighted-average basic shares outstanding rose from 8.5 million in Q1 2025 to 19.4 million in Q1 2026, creating significant dilution risk for existing shareholders.
  • Revenue has deteriorated rapidly, falling 100% sequentially in Q1 2026 and leaving the company without reported operating revenue to offset its $11.5 million in quarterly operating expenses.
  • Retained earnings remained deeply negative at approximately $1.27 billion, reflecting the company’s long history of accumulated losses. Despite positive reported equity in Q1 2026, the balance sheet remains dependent on future financing and successful development efforts.
08/19/26 12:11 PM ETAI Generated. May Contain Errors.

Curis Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Curis' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Curis' net income appears to be on a downward trend, with a most recent value of -$7.58 million in 2025, falling from -$58.98 million in 2015. The previous period was -$43.39 million in 2024. View Curis' forecast to see where analysts expect Curis to go next.

Curis' total operating income in 2025 was -$5.71 million, based on the following breakdown:
  • Total Gross Profit: $9.44 million
  • Total Operating Expenses: $15.16 million

Over the last 10 years, Curis' total revenue changed from $7.88 million in 2015 to $9.44 million in 2025, a change of 19.9%.

Curis' total liabilities were at $14.50 million at the end of 2025, a 69.3% decrease from 2024, and a 52.4% decrease since 2015.

In the past 10 years, Curis' cash and equivalents has ranged from $5.06 million in 2025 to $129.61 million in 2020, and is currently $5.06 million as of their latest financial filing in 2025.

Over the last 10 years, Curis' book value per share changed from 0.50 in 2015 to 0.42 in 2025, a change of -15.9%.


Related Companies

Financial statements for NASDAQ:CRIS last updated on 7/30/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel